None listed
Conditions
Interventions
Medical Device : The experimental group prospectively collected data from 20 patients who underwent robot-assisted retrograde intrarenal stone surgery using the automated system robotic surgical machi
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: * Test group 1. Study subjects aged 19 to 80 years 2. Patients with a total maximal diameter of renal stones = 20 mm and who are scheduled for retrograde intrarenal surgery (RIRS). 3. Those who have given written consent to the clinical trial contents that they are familiar with 4. Those scheduled to undergo surgery using a flexible ureteroscope Lithovue (Boston Scientific) *Control group 1. Patients aged 19 to 80 years 2. Patients with a total maximal diameter of renal stones = 20 mm and who are scheduled for retrograde intrarenal surgery (RIRS). 3. Patients who underwent surgery for kidney stones between January 2017 and June 2024 using a flexible ureteroscope Lithovue (Boston Scientific) 4. Patients who have been followed up for 6 months after surgery
Exclusion criteria
Exclusion criteria: * test group 1 A person who has not consented to a clinical trial 2 Patients with anatomical abnormalities in the urinary system (such as horseshoe or optoptic kidney, ureteral duplication, ureteropelvic motion construction, etc.) 3 Patients with uncontrolled medical conditions (such as severe cardiac disease [ASA class 3 or 4], severe respiratory disease, etc.) 4 Those who are unable to discontinue anticoagulant therapy and antiplatelet medication (except aspirin) 5 If you have bilateral stones and need to remove them at the same time 6 In retrograde endocrine stone surgery, other interventional surgeries must also be performed (prostate hypertrophy, renal ureteral transition and ureteral stenosis, ureteral carcinoma, kidney diverticulum, etc.) 7 A person who has received a kidney transplant 8 A person diagnosed with chronic kidney disease 9 Active Urinary Fact Infection (UTI) 10 Pregnant 11 A person who overreacts to a contrast medium and has difficulty controlling it 12 When both local and general anesthesia are difficult 13 A person who is currently participating in another clinical trial or who has participated in another clinical trial within 30 days as of the screening date 14 In addition, when the tester determines that participation in the clinical trial is inappropriate because it may affect the outcome of the clinical trial ethically or as a result of the clinical trial * a control group 1 A patient who has undergone bilateral kidney stones 2 Patients with other interventional surgeries (prostate hypertrophy, renal ureteral transition and ureteral stenosis, ureteral carcinoma, kidney diverticulum, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| stone removal rate | — |
Secondary
| Measure | Time frame |
|---|---|
| prognostic factors affecting surgical performance | — |
Countries
Korea, Republic of
Contacts
Public Contactseola Jung
Asan Medical Center
Outcome results
None listed